Of the 12,852 cancer-related trials identified [on clinicaltrials.gov in 2012], 7,776 (60%) were eligible for inclusion. Overall, 935 trials failed to complete; the most common reason was poor accrual (39%).

Source: JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju229, https://doi.org/10.1093/jnci/dju229

Almost 80% of clinical trials fail to meet enrolment timelines, meaning that the process of translating lab research into potentially life-saving treatments is often severely delayed.

*Source: Clinical trial delays: America’s patient recruitment dilemma, July 18, 2012 https://www.clinicaltrialsarena.com/analysis/featureclinical-trial-patient-recruitment/

A survey of 1,000 healthy adults showed that 40% of the survey participants did not understand the idea of a clinical trial. However 32% indicated that they would be very willing to participate in a cancer clinical trial if asked to do so.

Source: 10.1200/JCO.2003.02.105 Journal of Clinical Oncology - published online before print September 21, 2016 http://jco.ascopubs.org/content/21/5/830.long

More than 80% of clinical trials in the U.S. fail to meet their patient enrollment timelines and 30% of patients drop out

Source: There’s a silent crisis in clinical research. And it’s not Covid-19, Kent Thoelke, Oct. 28, 2020, Stat

13 studies involving almost 9,000 cancer patients found that over 50% of patients didn't have a trial available to them at their institution.

Source: JNCI: Journal of the National Cancer Institute, Volume 111, Issue 3, March 2019, Pages 245–255, https://doi.org/10.1093/jnci/djy221